Pfizer’s Accord for a Healthier World initiative aims to provide the company’s current and upcoming patented medicines at not-for-profit prices to 45 low and lower-middle-income countries to reduce health disparities. “At the heart of it is a fundamental belief that these are not tradeoffs. Doing social good and sustaining the long-term financial health of a company are two things that can fit wonderfully together,” Pfizer Executive Vice President and Chief Business Innovation Officer Aamir Malik said during a fireside investor...